Jacinda C Abdul-Mutakabbir
Overview
Explore the profile of Jacinda C Abdul-Mutakabbir including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
413
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marcelin J, Khazanchi R, Lyden E, Cawcutt K, Abdul-Mutakabbir J, Ha D, et al.
Open Forum Infect Dis
. 2025 Feb;
12(2):ofaf024.
PMID: 39963695
Background: Specialty societies, including the Infectious Diseases Society of America, strive to address gender and racial inequities in professional advancement. Microaggressions remain a persistent and pervasive barrier to these goals....
2.
Shremo Msdi A, Ravari A, Abdul-Mutakabbir J, Tan K
Infect Dis Ther
. 2025 Feb;
PMID: 39962022
Introduction: This study compared the calculated vancomycin area under the curve (AUC) using trapezoidal and non-trapezoidal first-order pharmacokinetic equations. Methods: This retrospective observational study included adult patients with documented MRSA...
3.
Abdul-Mutakabbir J, Kiles T, Allen J, Campbell H
J Am Coll Clin Pharm
. 2024 Dec;
7(6):520-522.
PMID: 39676881
No abstract available.
4.
Abdul-Mutakabbir J, Saunders I, Bandali A, Ko C, Nussbaum B, Brown S, et al.
Am J Health Syst Pharm
. 2024 Oct;
82(6):257-264.
PMID: 39425962
No abstract available.
5.
Wilk S, Abdul-Mutakabbir J, Doron S, Yen C, Berk J, Wurcel A
Lancet
. 2024 Sep;
404(10457):1015-1016.
PMID: 39277283
No abstract available.
6.
Shremo Msdi A, Abdul-Mutakabbir J, Tan K
Infect Dis Ther
. 2024 Jun;
13(8):1807-1819.
PMID: 38922527
Introduction: Methicillin-resistant Staphylococcus aureus (MRSA) infections are a serious threat to public health. Vancomycin (VAN) remains the primary treatment for these infections, and achieving the recommended area under the curve...
7.
Abdul-Mutakabbir J, Tan K, Johnson C, McGrath C, Zerr D, Marcelin J
Antimicrob Steward Healthc Epidemiol
. 2024 May;
4(1):e74.
PMID: 38721493
Health equity gaps persist across minoritized groups due to systems of oppression affecting health-related social needs such as access to transportation, education and literacy, or food and housing security. Consequently,...
8.
Wurcel A, Abdul-Mutakabbir J, Doron S, Yen C, Berk J
AMA J Ethics
. 2024 May;
26(5):E399-407.
PMID: 38700524
Antimicrobial resistance is a global threat that inequitably affects minoritized populations, including Black, Latinx, and Indigenous people-especially in carceral settings-and is largely driven by inappropriate antimicrobial prescribing practices. People whose...
9.
Hong L, Downes K, FakhriRavari A, Abdul-Mutakabbir J, Kuti J, Jorgensen S, et al.
Pharmacotherapy
. 2024 Feb;
44(2):208-209.
PMID: 38362632
No abstract available.
10.
Marcelin J, Hicks L, Evans C, Wiley Z, Kalu I, Abdul-Mutakabbir J
Infect Control Hosp Epidemiol
. 2024 Feb;
45(4):412-419.
PMID: 38351853
No abstract available.